Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ViiV Healthcare
Pharma
WHO flags increasing resistance to GSK's Tivicay in 4 countries
WHO's latest HIV Drug Resistance report highlighted surveys from four countries with increasing rates of resistance to Tivicay.
Zoey Becker
Mar 6, 2024 2:02pm
GSK's long-acting HIV med beats daily pills in some patients
Feb 21, 2024 2:00am
Colombia to seek compulsory license on ViiV's dolutegravir
Oct 4, 2023 3:00pm
GSK sees £7B in HIV sales by 2026, updates next-gen timelines
Sep 28, 2023 9:00am
MSF calls out GSK's ViiV for nondisclosure clauses in contract
Aug 17, 2023 2:54pm
In switching study, patients preferred J&J, ViiV drug over rival
Jul 25, 2023 9:32am